# Advanced Breast Cancer Therapies

{
  "id": "T12829",
  "title": "Advanced Breast Cancer Therapies",
  "url": "/topics/T12829",
  "kind": "topic-directory",
  "aeo_cohort": "topic-directory",
  "provider": "openalex",
  "revision": "e5c9e52f2a554e9f",
  "catalogue_revision": "f050b5d4780b1289",
  "numeric_address": "38351791289445674",
  "address_version": "morton4x16-v1",
  "coordinates": [
    4,
    27,
    2740,
    12829
  ],
  "answer_status": "Directory metadata; local answer requires separate source review",
  "truth_status": "Subject descriptor, not a factual answer or a demonstrated knowledge gap"
}

This cluster of papers focuses on the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, letrozole, ribociclib, and abemaciclib, in the treatment of hormone receptor-positive metastatic breast cancer. The papers cover various aspects including clinical trials, mechanisms of action, therapeutic resistance, combination strategies, and potential biomarkers.

Directory metadata is not a factual answer or evidence of a global knowledge gap.

Source: https://openalex.org/T12829

No owner-reviewed local answer yet.